Statistical Solutions: %RSD: Friend or Foe? - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Statistical Solutions: %RSD: Friend or Foe?
When to use percent relative standard deviation—and how to do so correctly.


Pharmaceutical Technology
Volume 34, Issue 1, pp. 37-38

Some tools are so useful and intuitive that they achieve widespread acceptance without recommendation. Percent relative standard deviation (%RSD) is one such tool. By formula, it is the standard deviation of a data set divided by the average of the data set multiplied by 100. Conceptually, it is the variability of a data set expressed as a percentage relative to its location. Statisticians know it as the coefficient of variation (CV) (1).


Lynn D. Torbeck
Analytical laboratories measure and understand variability to estimate product quality. For most analytical laboratory staff and management, the %RSD is used extensively as a universal measure of that variability. It is a general yardstick for chemists for analysis and interpretation.

The understandable appeal lies in its simplicity and in its expression as a percentage. People interpret percentages more easily than the standard deviation in units of, for example, mg/mL.

An advantage of the %RSD is that comparisons can be made across dissimilar results. In fact, the first use was to compare men and women. In 1895, the geneticist and statistician Karl Pearson calculated the averages and standard deviations of male and female internal organs. The men were larger and had larger variability. To compare them on the same basis, he adjusted the standard deviation of each by dividing by the average of each. Multiplying by 100 then yielded a percentage.

%RSD is most beneficial for comparisons where the units of the measurements are different, for example mg/mL and absorbance. It provides a common base for comparison.


Table I: Example of a misleading standard deviation (SD).
While %RSD is clearly useful, care is needed in the application and interpretation because of its statistical properties. For example, it should only be used where zero for the measurement has real physical meaning such as length, weight, or area under the curve. Don't use it where zero is arbitrary, such as pH.


Table II: Example of a standard deviation (SD) that is proportional to the average.
The %RSD is also useful when the standard deviation is proportional to the average. If the standard deviation doesn't change much over the range of the group averages, it can be misleading as shown in Table I. Note that the %RSD is changing because the average is changing, not the standard deviation. In Table II, the standard deviation is proportional to the average and the %RSD is unchanged.

Good documentation requires reporting the sample size, average, and standard deviation with the %RSD. The %RSD is misleading when used with data that are expressed as a percentage such as percent recovery. The standard deviation of the data is already in percent. To then find the %RSD is to make the results dependent on the random variation of the average. This defeats the original purpose of estimating the variation of the data values.


How to work with the percent relative standard deviation tool (%RSD).
The %RSD is not useful for data with a very small average. As the average gets smaller, the %RDS gets larger, approaching infinity as the average approaches zero, which is not a desirable result. It is not useful for limit of quantitation and limit of detection for example.

Estimates of the standard deviation and thus the %RSD are very poor for small sample sizes. There is considerable variation in the estimates of variation when the sample sizes are small. For example, for a sample of 10 data points with 95% confidence, the maximum percent error in estimating the standard deviation can be as large as 50% (2). This variation also illustrates that a calculated standard deviation or %RSD is not a fixed value. Another sample would yield a different value for both.

Following the dictum of the right tools for the job, use the %RSD but do it correctly.

Lynn D. Torbeck is a statistician at Torbeck and Assoc.,2000 Dempster Plaza, Evanston, IL 60202, tel. 847.424.1314,
, http://www.torbeck.org/.

References

1. K. Pearson, Phil. Tans. Royal Soc. London (A), 187, 253–318 (1896).2. L. S. Nelson, Jrnl. of Quality Technol., 8 (3), 179–180 (1976).

ADVERTISEMENT

post a comment
Your email address will NOT be published.
appears with your comment
read our privacy policy
Note: does not support HTML
All comments submitted are subject to review, and may be delayed before posting. We reserve the right not to post comments.
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
Looking forward 10 years from now, what do you think will be the most significant change to drug development and manufacturing?
Fuller adoption of quality by design principles
Greater adoption of continuous manufacturing
A stronger movement to personalized medicine and the use of diagnostics with traditional pharmaceuticals
The rise of biologic-based drugs in commercial product portfolios and pipelines
Greater adoption of the preferred provider model in outsourcing
Fuller adoption of quality by design principles
22%
Greater adoption of continuous manufacturing
7%
A stronger movement to personalized medicine and the use of diagnostics with traditional pharmaceuticals
35%
The rise of biologic-based drugs in commercial product portfolios and pipelines
30%
Greater adoption of the preferred provider model in outsourcing
7%
View Results
Jim MillerOutsourcing OutlookJim Miller Channeling Steve Jobs
Patricia Van ArnumIngredients InsiderPatricia Van ArnumSeeking Chemocatalytic and Biocatalytic Solutions
Nathan JessopIndustry InsiderNathan Jessop Taxing Times for French Pharma
Lynn D. TorbeckStatistical Solutions Lynn D. TorbeckRepresentative Sampling
Report on Recent and Upcoming Single-Use Meetings
ICH Q11 Reaches Harmonization, Implementation is Next
Digital Signatures Growing as a Result of Part 11
Single-Cell Genomics Advancing Molecular Biology
Putting FDA’s “Process Validation” Guidance into Action
FindPharma Custom Search
Source: Pharmaceutical Technology,
Click here